Eagle Pharmaceut (EGRX) Total Assets by Year
Eagle Pharmaceut closed fiscal year 2022 with $406.2M in total assets, $172.6M in total liabilities and $233.6M in shareholder equity. This represents an increase of 60.1% from the prior fiscal year. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters Eagle Pharmaceut has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EGRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $406.2M+60.1% | $253.7M+0.2% | $253.2M-0.5% | $254.6M+6.7% | $238.6M-11.6% | $270.1M+26.0% | $214.3M+72.0% | $124.6M+133.3% | $53.4M+195.0% | $18.1M | N/A |
| Total Liabilities | $172.6M+123.3% | $77.3M+15.0% | $67.2M-10.9% | $75.4M-3.2% | $77.8M-14.4% | $90.9M+44.1% | $63.1M+84.2% | $34.3M+68.7% | $20.3M-80.8% | $106.0M | N/A |
| Total Equity | $233.6M+32.4% | $176.5M-5.1% | $186.0M+3.8% | $179.2M+11.5% | $160.8M-10.3% | $179.1M+18.5% | $151.2M+67.4% | $90.3M+173.0% | $33.1M+137.6% | -$87.9M+5.9% | -$93.4M |
EGRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q | Q1'2110-Q | Q4'2010-K | Q3'2010-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $404.8M+6.0% | $414.2M+29.4% | $406.2M+60.1% | $386.4M+50.8% | $381.8M+44.5% | $320.2M+23.2% | $253.7M+0.2% | $256.3M+3.3% | $264.2M+2.9% | $260.0M-28.2% | $253.2M-0.5% | $248.2M-3.5% |
| Total Liabilities | $152.8M+6.3% | $171.3M+64.4% | $172.6M+123.3% | $154.7M+117.9% | $143.8M+107.2% | $104.2M+51.3% | $77.3M+15.0% | $71.0M-5.8% | $69.4M-4.6% | $68.9M-61.8% | $67.2M-10.9% | $75.4M-7.3% |
| Total Equity | $252.0M+5.9% | $242.8M+12.4% | $233.6M+32.4% | $231.8M+25.1% | $238.0M+22.1% | $216.0M+13.0% | $176.5M-5.1% | $185.3M+7.2% | $194.8M+5.9% | $191.1M+5.1% | $186.0M+3.8% | $172.8M-1.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Eagle Pharmaceut financials
Frequently Asked Questions
What was Eagle Pharmaceut's total assets in fiscal year 2022?
Eagle Pharmaceut closed fiscal year 2022 with $406.2M in total assets, $172.6M in total liabilities and $233.6M in shareholder equity.
How fast is Eagle Pharmaceut's total assets growing?
Eagle Pharmaceut (EGRX) total assets rose by 60.1% year over year, from $253.7M to $406.2M in fiscal year 2022.
What was Eagle Pharmaceut's total assets in the most recent quarter?
Eagle Pharmaceut (EGRX) reported $404.8M in total assets in Q2 2023. This represents an increase of 6.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Eagle Pharmaceut (EGRX) reported on that line in every period on record.